U.S. Markets close in 38 mins

Wall Street Analysts Are Mostly Positive about Johnson & Johnson

Daniel Collins
Wall Street Analysts Are Mostly Positive about Johnson & Johnson

In June, Johnson & Johnson (JNJ) accepted a binding offer from Platinum Equity to acquire its LifeScan business for ~$2.1 billion. LifeScan is a global leader in manufacturing blood glucose monitoring devices and manufactures the OneTouch brand. LifeScan estimates that more than 20.0 million individuals worldwide depend on the OneTouch brand of products for the management of diabetes.